Is someone you care for with Alzheimer’s dementia exhibiting excessive motor activity, verbal and/or physical aggression?
If so, they may qualify for the ASPECT clinical research study. The purpose of this study is to evaluate the safety and effectiveness of an investigational drug for agitation associated with Alzheimer’s dementia.
To be eligible for this study, a potential participant must:
– Be between the ages of 50 and 90
– Have a diagnosis of probable Alzheimer’s dementia
– Have moderate-to-severe agitation that interferes with their daily life
– Have a reliable caregiver who spends a minimum of 2 hours per day, 4 days per week with them and is willing and able to comply with all study procedures
*Other eligibility criteria may apply.
Those who qualify will receive study-required medical care and study drug at no cost. Health insurance is not required.
If you are interested in participating in this study, please complete the following preliminary qualification form.
We will follow-up with you after we have received your submission.